Digipath
Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

Arrayit Microarray product line has been recently submitted

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Top Stock Picks Member Profile
Member Level 
Followed By 420
Posts 32,534
Boards Moderated 22
Alias Born 04/26/12
160x600 placeholder
Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider GlobeNewswire Inc. - 12/3/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health GlobeNewswire Inc. - 11/19/2018 5:30:00 AM
Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing GlobeNewswire Inc. - 11/5/2018 5:30:00 AM
Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business GlobeNewswire Inc. - 11/1/2018 5:30:00 AM
Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics GlobeNewswire Inc. - 10/22/2018 5:30:00 AM
Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists GlobeNewswire Inc. - 10/8/2018 5:30:00 AM
Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration GlobeNewswire Inc. - 9/24/2018 5:30:00 AM
Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services GlobeNewswire Inc. - 9/10/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers GlobeNewswire Inc. - 8/27/2018 5:30:00 AM
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain GlobeNewswire Inc. - 8/13/2018 5:30:00 AM
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics GlobeNewswire Inc. - 7/30/2018 5:30:00 AM
Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration GlobeNewswire Inc. - 7/16/2018 5:30:00 AM
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains GlobeNewswire Inc. - 7/2/2018 5:30:00 AM
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network GlobeNewswire Inc. - 6/18/2018 5:30:00 AM
Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement GlobeNewswire Inc. - 5/30/2018 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/9/2018 1:55:34 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/22/2018 2:12:50 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/19/2018 6:37:10 PM
Top Stock Picks Member Level  Monday, 01/14/19 12:02:50 AM
Re: None
Post # of 118069 
Arrayit Microarray product line has been recently submitted to the FDA and is now pending approval

1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov

AllergyPro
http://www.labpharmllc.com/emailblast/allergy.html

“our comprehensive Allergy Program Offering, Including Allergy Labs of America, Allergy-Pro and the New Finger Stick Blood Drop Allergy Cards. The bulk of the call will also be discussing 2 new Lab Partners that we have recently added to our network.”


https://s3.amazonaws.com/bbemail/PROD/ulib/p5d1n/docs/73d0e7a8-72f3-5203-445b-dfea5f12a989/HMAllergyProSales11.12.16.pdf


AllergyPro/AllergyGo Website Disclaimer:

The services on this website are provided by ARRAYIT CORPORATION, a Nevada corporation (“Arrayit”) and ALLERGYGO, LLC, a Texas limited liability company (“AllergyGo”). Arrayit is in the business of developing and manufacturing certain proprietary life science technologies for disease prevention and treatment, specifically including advanced blood card technology with IgE microarray testing for allergens (“Tests”), and AllergyGo is in the business of marketing and distributing allergy testing products.

http://allergygo.com/

Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding FDA approval of a major product line, reported the sale of clinical instrumentation to the FDA, signed allergy testing contracts with a consortium of 178 medical clinics and received approval for in-store promotions by a major retailer. Arrayit’s new therapeutics partners provide a seamless solution to doctors who diagnose and treat the more than 50 million Americans reporting allergic symptoms annually.

http://www.arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_Corporation_Announces_/arrayit_corporation_announces_allergy_testing_partnerships_with_.html




Market’s first high-performance blood card technology... Blood card technology is pending 510(k) submission and is not to be used for in vitro diagnostics prior to FDA approval.

http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html

510(k) Clearance to Market:

The majority of Class II medical devices are cleared to market by submission and FDA review of a 510(k) Pre-Market Notification submission. The 510(k) submission identifies characteristics of the new or modified medical device as compared to a medical device with similar intended use, currently legally marketed in the United States. The currently legally marketed device is referred to as the “predicate” device.

Depending on the complexity of the new or modified medical device, the FDA Review of a 510(k) submission takes between 20 and 90+ days. The more complex the changes or comparison required to support the safety and effectiveness of the new or modified medical device, the longer the FDA review process.

http://www.qrasupport.com/FDA_MED_DEVICE.html



9-24-18 Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration

https://www.yahoo.com/amphtml/finance/news/arrayit-corporation-ships-clinical-instrumentation-093000351.html

Verify the above mentioned FDA process here:

https://www.fpds.gov/ezsearch/fpdsportal?q=arrayit&s=FPDSNG.COM&templateN=&&templateName=1.5.1&indexName=awardfull

1-3-18 Arrayit advanced microarray technology to be incorporated into a clinical trial by a major pharmaceutical giant in a development that could significantly increase revenues and earnings in 2018 arrayit.com/Products/products.html



Kaiser Permanente?
5/11/18: Arrayit prototyping team completes custom whole blood collection card for $64.6 billion health maintenance organization HMO leader Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11,700,000 members in 8 states (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org

5/25/2018: Arrayit CLIA clinical team completes allergy testing sample collection kits for health maintenance organization (HMO) giant Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare for 11.7 million health plan members (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org


5/29/2018: Arrayit CLIA clinical team delivers complimentary wellness test kits and requisition forms to the nation's leading health maintenance organization HMO Kaiser Permanente HQ in Oakland California USA and providing premium healthcare to 11.1 million members (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org



5/31/2018: Arrayit CLIA clinical team schedules follow up visit regarding allergy testing with the world's largest health maintenance organization HMO Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare to 11,100,000 patients (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org



6/14/2018: Arrayit CLIA clinical team submits Client Services Manual to $64.6 billion health maintenance organization HMO leader Kaiser Permanente headquartered in Oakland California USA and providing premium healthcare services and care for 11.7 million patients (link: https://healthy.kaiserpermanente.org) healthy.kaiserpermanente.org


https://mobile.twitter.com/arrayit/status/994975187224346624/photo/1


Arrayit private labeling Blood Card technology is pending 510(k) approval by the FDA.


http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html


Kaiser Permanente laboratories and Quest Diagnostics Inc.(Quest) provide all outpatient laboratory services for members in the KPMAS Service Area.

http://providers.kaiserpermanente.org/info_assets/cpp_mas/mas_provman_ch11.pdf


Quest Diagnostics partnership?

https://questallergy.com/

https://www.questdiagnostics.com/home/patients/scheduling-test/food-and-drug-retail-locations.html


“Fingerstick Screenings from Quest Diagnostics Health & Wellness”

http://www.questforhealth.com/resources/product-overviews/fingerstick-screenings-quest-diagnostics-health-wellness/


ImmunoCAP Specific IgE Blood Test

https://www.questdiagnostics.com/testcenter/testguide.action?dc=TS_ImmunoCapIgE


Further, please take the time to read the due diligence report down below for additional revenue streams. The information contained in the report regarding this undervalued Silicon Valley biotech stock is incredible.

https://cdn.discordapp.com/attachments/423182137190252545/460999366761644053/Arrayit_Due_Diligence_Report_.pdf



:)

All my posts are my opinion only. Please do your due diligence on all your investments.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist